1. 3'-Azido-3'-deoxythvmidine (BW A509U): an antiviral agent that inhibits the infectivity and cvtopathic effect of human T-lymphotropic virus type I11/lymphadenopathy-associated;Mitsuva, H.; Weinhold, K.J.; Furman, P.A.; NIHS, Clair; Lehrman, S.N.; Gallo, R.C.,1985
2. The efficacy of azidothymidine (AzT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind placebo-controlled trial;Fischl, M.A.; Richman, D.D.; MiH, Grieco; Gottlieb, M.S.; Volberding, P.A.; Laskin, O.L.; et a1;N EnglJ. Ued,1987
3. Effects of zidos-udine in 365 consecutise patients with AIDS or AIDS-related complex;Dournon, E.; Matheron, S.; Rozenbaum, W.; Gharakhanian, S.; Michon, C.; Girard, P.M.; ei al;Iancet,1988
4. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex;Fischl, M.A.; Richman, D.D.; Causey, D.M.; Grieco, M.H.; Br-son, Y.; Mildvan, D.,1989
5. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind placebo-controlled trial. N Englj. ed 1987;317:192-7.